Project Grant R21AA031414
Award Date
9/20/24
Completion Date
8/31/26
Dollars Obligated
$224K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $1,261,026 federal Project Grant award was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to the University of North Carolina at Chapel Hill (UNC-CH). The award period is from April 18, 2024 to January 31, 2029.
The objective of this research project is to use a multi-faceted approach integrating machine learning, genetic manipulations, in vivo imaging, and ex vivo physiology to investigate the role of...
This $223,531 Project Grant awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research at the University of North Carolina at Chapel Hill (UNC-CH) on the role of perineuronal nets in adolescent alcohol-induced cognitive and behavioral deficits. The research aims to determine if enzymatically degrading perineuronal nets in the orbitofrontal cortex of rats exposed to adolescent intermittent ethanol can...
This federal Project Grant award of $214,385 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to develop a novel in vivo model called CHIMERA-BONCAT. This innovative approach will allow for comprehensive, unbiased, and cell-type-specific characterization of the human microglial response to alcohol using induced pluripotent stem cell-derived human microglia in a chimeric mouse model. The project, led by...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs federal grant program (CFDA 93.273), provides $545,282 to study neural mechanisms underlying alcohol use disorder (AUD) and recovery during early abstinence. The award, granted on September 1, 2024, aims to determine how neural function associated with cognitive reappraisal and alcohol cue reactivity changes across the initial period of abstinence during...
This federal Project Grant award for $479,164 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) seeks to identify additional genetic polymorphisms related to choline metabolism that impact behavioral outcomes in individuals with prenatal alcohol exposure (PAE).
The project has two main aims: 1) to test the hypothesis that polymorphisms in additional choline-related genes influence behavioral outcomes in those with PAE who...
This $468,534 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a study examining the implications of midlife alcohol use for the risk of developing Alzheimer's disease and related dementias (ADRD). The primary objectives are to:
Delineate the relationship between midlife alcohol consumption and late-life ADRD diagnosis and onset, considering potential sex differences.
Evaluate the interaction between alcohol consumption and APOE...
This $594,784 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support a postmortem, multi-omic study of brains from 341 subjects with alcohol use disorder (AUD), major depressive disorder, and neurotypical controls. The study aims to identify novel lasting transcriptomic and epigenetic changes in biological pathways that could serve as biomarkers and therapeutic targets for...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research on the role of oligodendrocytes in cognitive decline associated with alcohol use disorder (AUD) and aging.
The $227,335 award, with a performance period from May 2024 to April 2026, will fund experiments using transgenic technology and cell fate mapping to investigate the cellular processes that lead to...
This $349,738 project grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding research at Ursinus College to investigate the role of microglial fractalkine signaling in altered dopaminergic wiring resulting from fetal alcohol spectrum disorders (FASD).
The research aims to (1) define the developmental timing of alcohol-induced alterations in fractalkine signaling, and (2) determine the impact of these changes...
The University of North Carolina at Chapel Hill (UNC-CH) received a $427,625 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) to develop and validate a computational framework for identifying excitation-inhibition imbalances in Alzheimer's disease (AD) using multi-modal neuroimaging data. The goal is to create an innovative technique that can noninvasively detect circuit-level disruptions in brain networks associated with AD pathology,...